Portfolio companies.
34,000+ PE-backed.

Active investments and exits across European private equity portfolios.
Filter by sector, geography, status. Find the right deal comp in seconds.

Active deals

currently held

Exits tracked

hand-checked

Sectors covered

across the portfolio

Countries covered

from every market

Latest activityLast event 2026-09-23

Caledonia InvestmentscapitalCapital Event · capital-cancellation-shares · Capital structure change1 week ago

Caledonia Investments1 week ago

Capital Event · capital-cancellation-shares · Capital structure change

capital

Caledonia InvestmentscapitalCapital Event · capital-cancellation-shares · Capital structure change1 week ago

Caledonia Investments1 week ago

Capital Event · capital-cancellation-shares · Capital structure change

capital

Caledonia InvestmentscapitalCapital Event · capital-cancellation-shares · Capital structure change1 week ago

Caledonia Investments1 week ago

Capital Event · capital-cancellation-shares · Capital structure change

capital

Elaia PartnersadminCEO change · Departure of CEO Gire, Philippe · CEO departure · leadership transition underway2 weeks ago

Elaia Partners2 weeks ago

CEO change · Departure of CEO Gire, Philippe · CEO departure · leadership transition underway

admin

Lauxera Capital PartnersadminBoard change · Management board member change: et Directeur général délégué Fracchia, Edoardo · Change in the management board1 month ago

Company	Sector	Geo	Investor	Entry	Hold	Status	Buyer	MOIC
Araris Biotech 4BIO Ventures II	Biotech	Switzerland	4Bio Partners	2020	5yr	Exited 2025	Taiho Pharmaceutical	–
Oculis Earlybird Health	Biotech	Switzerland	Earlybird Venture Capital	2020	3yr	Exited 2023	–	–
T3 Pharmaceuticals Boehringer Ingelheim Venture Fund	Biotech	Switzerland	Boehringer Ingelheim Venture Fund	2019	4yr	Exited 2023	Boehringer Ingelheim	–
VectivBio Sofinnova Capital VIII	Biotech	Switzerland	Sofinnova Partners	2017	6yr	Exited 2023	Ironwood Pharmaceuticals	–
Noema Pharma2 periods Jeito I	Biotech	Switzerland	Jeito Capital	2020	3yr	Active	–	–
Versantis Invivo Ventures	Biotech	Switzerland	Invivo Partners	2017	5yr	Exited 2022	Genfit	–
Sophia Genetics5 periods Eurazeo Growth Fund III	Biotech	Switzerland	Eurazeo	2014	7yr	Active	–	–
evitria2 periods AFINUM VIII Buyout (2017)	Biotech	Switzerland	AFINUM Management GmbH	2018	3yr	Exited 2021	Atlas Antibodies	–
Arvelle BioDiscovery 5	Biotech	Switzerland	Andera Partners	2019	2yr	Exited 2021	Angelini Pharma	–
NBE Therapeutics Boehringer Ingelheim Venture Fund	Biotech	Switzerland	Boehringer Ingelheim Venture Fund	2013	7yr	Exited 2020	Boehringer Ingelheim	–
Amal Therapeutics2 periods Boehringer Ingelheim Venture Fund	Biotech	Switzerland	Boehringer Ingelheim Venture Fund	2014	5yr	Exited 2019	Boehringer Ingelheim	–
ObsEva Sofinnova Capital VIII	Biotech	Switzerland	Sofinnova Partners	2015	2yr	Exited 2017	–	–
GENEPEP Naxicap Legacy Funds	Biotech	Switzerland	Naxicap Partners	2007	9yr	Exited 2016	TWO-C	–
GlycoVaxyn Sofinnova Capital VII	Biotech	Switzerland	Sofinnova Partners	2012	3yr	Exited 2015	GSK	–
Okairos Boehringer Ingelheim Venture Fund	Biotech	Switzerland	Boehringer Ingelheim Venture Fund	2011	2yr	Exited 2013	GlaxoSmithKline	–
Addex Therapeutics Sofinnova Capital VI	Biotech	Switzerland	Sofinnova Partners	2008	4yr	Exited 2012	–	–
PregLem Sofinnova Capital VI	Biotech	Switzerland	Sofinnova Partners	2006	4yr	Exited 2010	Gedeon Richter	–
Evolva Sunstone Life Science Ventures III	Biotech	Switzerland	Sunstone Life Science Ventures	2005	4yr	Exited 2009	–	–
Cytos Biotechnology AG HealthCap (early funds)	Biotech	Switzerland	HealthCap	1999	3yr	Exited 2002	–	–
Haya Therapeutics3 periods Earlybird Health	Biotech	Switzerland	Earlybird Venture Capital	2021	5yr	Active	–	–
Cellvie2 periods Oscar & Paul Venture Capital Fund I	Biotech	Switzerland	Oscar & Paul (Beiersdorf Venture Capital)	2021	5yr	Active	–	–
Page Therapeutics2 periods XGEN Venture Life Sciences Fund	Biotech	Switzerland	XGen Venture SGR	2024	2yr	Active	–	–
AL-S Pharma AG TVM Life Science Innovation	Biotech	Switzerland	TVM Capital Life Science	2016	10yr	Active	–	–
Alentis HTGF III	Biotech	Switzerland	High-Tech Gruenderfonds (HTGF)	2019	7yr	Active	–	–
Bright Peak Therapeutics TVM Life Science Ventures	Biotech	Switzerland	TVM Capital Life Science	2020	6yr	Active	–	–
ExcellGene MED Rise	Biotech	Switzerland	ARCHIMED	2025	1yr	Active	–	–
Focal Biosciences Apollo Health Ventures Fund II	Biotech	Switzerland	Apollo Health Ventures	2022	4yr	Active	–	–
InCephalo HTGF IV	Biotech	Switzerland	High-Tech Gruenderfonds (HTGF)	2023	3yr	Active	–	–
InSphero ZEISS Ventures CVC	Biotech	Switzerland	ZEISS Ventures	2023	3yr	Active	–	–
iOnctura XGEN Venture Life Sciences Fund	Biotech	Switzerland	XGen Venture SGR	2024	2yr	Active	–	–
PreComb HTGF III	Biotech	Switzerland	High-Tech Gruenderfonds (HTGF)	2021	5yr	Active	–	–
Stragen MED III	Biotech	Switzerland	ARCHIMED	2021	5yr	Active	–	–
Synendos Therapeuthics HTGF III	Biotech	Switzerland	High-Tech Gruenderfonds (HTGF)	2020	6yr	Active	–	–
Hoba Therapeutics3 periods EIFO (direct equity)	Biotech	Switzerland	Eifo	2022	4yr	Active	–	–
Atlas Bio2 periods LEA Venturepartner (VC)	Biotech	Switzerland	LEA Partners	2024	2yr	Active	–	–
GlycoEra2 periods LifeArc Ventures	Biotech	Switzerland	LifeArc	2021	5yr	Active	–	–
arcoris bio ZEISS Ventures CVC	Biotech	Switzerland	ZEISS Ventures	2025	1yr	Active	–	–
Dimericon HTGF IV	Biotech	Switzerland	High-Tech Gruenderfonds (HTGF)	2023	3yr	Active	–	–
Engimmune Therapeutics Novo Holdings Seed Investments	Biotech	Switzerland	Novo Holdings	2022	4yr	Active	–	–
Numab Therapeutics Novo Holdings Growth Investments	Biotech	Switzerland	Novo Holdings	2021	5yr	Active	–	–
PAGE Therapeutics AG KIZOO Evergreen (Balance Sheet)	Biotech	Switzerland	KIZOO Technology Capital	2023	3yr	Active	–	–
SwitchKine Boehringer Ingelheim Venture Fund	Biotech	Switzerland	Boehringer Ingelheim Venture Fund	2024	2yr	Active	–	–
TECregen Boehringer Ingelheim Venture Fund	Biotech	Switzerland	Boehringer Ingelheim Venture Fund	2023	3yr	Active	–	–
Windward Bio AG Novo Holdings Venture Investments	Biotech	Switzerland	Novo Holdings	2026	0yr	Active	–	–

Portfolio companies.34,000+ PE-backed.

Portfolio companies.
34,000+ PE-backed.